ViiV Healthcare Introduces “Do It for Future You” Campaign for Sexual Wellness

In August 2026, ViiV Healthcare introduced the “Do It for Future You” campaign, which is a multichannel campaign that is intended to inspire people to take care of their health in the present to ensure better future health. This campaign encourages individuals to discuss with healthcare professionals long-acting injectable HIV prevention and treatment options.

This campaign conveys a clear message that the choices a person makes today affect their future. Rapid advancement in the medical industry has transformed H.I.V from a fatal disease to a manageable chronic condition. Over 39,000 U.S. citizens are diagnosed with HIV every year.

There are significant gaps in terms of awareness and the availability of treatments. Only around one-fourth of the patients suffering from H.I.V who could benefit from pre-exposure prophylaxis (PrEP) benefit from it. Only around 69 percent of people who suffer from H.I.V have achieved viral suppression. It helps them protect their health in the future and also prevents further spread of the disease.

These gaps in healthcare for patients could be narrowed down using the Long-acting injectable (LAI) options, which have been proven to improve compliance and consistency in HIV medicine. It helps to achieve consistent viral suppression and protection from H.I.V. This initiative will help patients to prevent further damage to their health and also reduce the transmission of the disease to other people. According to Bithiah Lafontant, Head of Enterprise Communications at ViiV Healthcare, the goal of this campaign is to make people aware that the health choices they make today are directly responsible for their future life.

Impact on the Healthcare Industry

According to Precedence Research, the launch of the “Do It for Future You” campaign is expected to positively impact the healthcare industry due to the fact that it increases awareness about HIV among people and encourages them to speak with healthcare professionals. Real-world analytics are proof that HIV patients are underserved and many even spread the disease to multiple people without their knowledge. This campaign will help many individuals to speak up, connect with medical professionals, and shape a better future for themselves.

Impact on the HIV Diagnostics Market

The global HIV diagnostics market size was calculated at USD 1.34 billion in 2025 and is predicted to increase from USD 1.41 billion in 2026 to approximately USD 2.24 billion by 2035, expanding at a CAGR of 5.26% from 2026 to 2035.

According to Precedence Research, the introduction of the “Do It for Future You” campaign is expected to benefit the HIV diagnostics market. This is owing to the fact that it encourages HIV patients to seek medical care and preserve their health as well as prevent further spread of the disease. It will result in higher adoption of HIV treatments as people become more and more aware of the disease and its treatments. This is an important initiative as undetected HIV can progress to AIDS, which is much more dangerous and has a significantly higher mortality rate than HIV. 

Impact on the Sexually Transmitted Diseases (STD) Diagnostics Market

The global sexually transmitted diseases (STD) diagnostics market size is estimated at USD 11.43 billion in 2025 and is predicted to increase from USD 12.26 billion in 2026 to approximately USD 22.99 billion by 2035, expanding at a CAGR of 7.24% from 2025 to 2035.

According to Precedence Research, the launch of the “Do It for Future You” campaign by ViiV Healthcare is expected to positively impact the sexually transmitted diseases (STDs) diagnostics market. This is owing to the fact that this campaign encourages people to prioritize their sexual health, which directly affects the future of the individual. The motto of the campaign emphasizes the role of today’s choices in our future lives. Many people suffering from STDs do not seek medical help out of shame.

This campaign wants to make people aware that seeking help can change the course of their lives. Such an initiative would encourage many people suffering from STDs but not speaking up out of shame to visit healthcare facilities and speak with professionals. It will lead to an increase in the adoption of STDs diagnostic platforms as people visit medical facilities to seek treatment.

About ViiV Healthcare

ViiV Healthcare is a global pharmaceutical company that is committed to preventing, treating, and curing HIV. The company focuses on providing innovative HIV treatments and long-term care. ViiV Healthcare has the vision to eradicate HIV and AIDS completely, and they strive continuously to reduce its impact on humanity.

The company was founded in 2009 through a partnership between GSK and Pfizer, and Shionogi joined in 2012. ViiV Healthcare has a total workforce of around 1,600 employees who are committed to improving the lives of people who are suffering from HIV. The company has labs in Branford, Connecticut, and Durham, North Carolina, where scientists drive the innovation to develop next-generation HIV treatments.